本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atara Biotherapeutics

7.67
+0.42005.79%
盘后7.670.00000.00%17:56 EDT
成交量:13.81万
成交额:111.11万
市值:4,493.78万
市盈率:-0.67
高:8.65
开:8.00
低:7.43
收:7.25
数据加载中...
2022/07/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/06/24

重要事件披露

8-K - Current report
2022/05/19

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/04/04

重要事件披露

8-K - Current report
2022/03/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/28

重要事件披露

8-K - Current report
2022/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

重要事件披露

8-K - Current report
2022/01/10

重要事件披露

8-K - Current report
2022/01/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals